An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat
Open Access
- 1 August 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 115 (7) , 1231-1234
- https://doi.org/10.1111/j.1476-5381.1995.tb15030.x
Abstract
1 Comparison of the rank order of potency of the natural prostanoids prostaglandin E2 (PGE2), PGD2, PGF2a and carbaprostacyclin in stimulating cyclic AMP in Jurkat cells is consistent with the presence of an EP receptor. 2 Lack of responsiveness to the EP1/EP3 selective agonist, sulprostone, and the EP2 agonists, butaprost and AH 13205, indicates that this receptor is not of the EP1, EP2 or EP3 subtypes. 3 Inhibition of PGE2-stimulated cyclic AMP by the EP4 antagonist, AH 23848 is non-competitive, unlike the competitive antagonism reported in the pig saphenous vein EP4 preparation. Furthermore, 16,16-dimethyl PGE2 is 100 fold less potent than PGE2 in Jurkat cells, while these agonists are equipotent in the rabbit jugular vein purported EP4 preparation. In addition, 1-OH PGE1 which also is active in the rabbit jugular vein preparation, is inactive in Jurkat cells at concentrations up to 1 × 10−4 m. These data are not wholly consistent with any adenylate cyclase coupled EP receptor described to date. 4 It is postulated that an EP receptor, positively coupled to adenylate cyclase, with a unique pharmacological profile is present in Jurkat cells.Keywords
This publication has 36 references indexed in Scilit:
- Location of cAMP-Dependent Protein Kinase Type I with the TCR-CD3 ComplexScience, 1994
- Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificityNature, 1993
- Characterization of the 3′,5′-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cellsCellular Immunology, 1991
- Effects of modulators of adenylyl cyclase on interleukin-2 production, cytosolic Ca2+ elevation, and K+ channel activity in Jurkat T cellsCellular Immunology, 1990
- Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cellsEuropean Journal of Immunology, 1988
- Lymphocyte Hormone ReceptorsAnnual Review of Immunology, 1987
- Prostaglandin E2 Receptors on Human Peripheral Blood MonocytesScandinavian Journal of Immunology, 1985
- High-affinity binding sites for prostaglandin E on human lymphocytesCellular Immunology, 1979
- PROLONGATION OF MURINE SKIN ALLOGRAFTS BY PROSTAGLANDIN ETransplantation, 1977
- Effect of Prostaglandin E1 on Adjuvant ArthritisNature, 1971